MindWalk Holdings (HYFT) EBITDA Margin (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly EBITDA Margin came in at 77.57% in Q2 2026, down 5330.0% year-over-year from 1.48% in Q2 2025, and up 12.21% quarter-over-quarter from 88.36% in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) EBITDA Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBITDA Margin for 7 consecutive years, with 77.57% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 5330.0% year-over-year to 77.57% in Q2 2026; TTM through Apr 2026 was 88.75%, a 10858.0% increase from a year earlier, with the FY2026 full-year figure at 96.01%, down 4247.0% from the prior year.
- EBITDA Margin was 77.57% for Q2 2026 at MindWalk Holdings, up from 88.36% in the prior quarter.
- Over five years, EBITDA Margin peaked at 287.01% in Q2 2024 and troughed at 120274.35% in Q3 2023.
- A 5-year average of 12014.27% and a median of 98.33% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 12006015 bps in 2023 and surged 12007726 bps in 2024, its largest moves.
- Over 5 years, EBITDA Margin stood at 150.93% in 2022, then tumbled by 62086 bps to 93854.41% in 2023, then jumped by 100 bps to 151.33% in 2024, then surged by 56 bps to 67.29% in 2025, then slipped by 15 bps to 77.57% in 2026.
- The last three EBITDA Margin figures came in at 77.57% (Q2 2026), 88.36% (Q1 2026), and 67.29% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 21.68% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 11.94% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 15.86% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -3.77% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -77.57% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -77.57% |
| Jan 31, 2026 | -88.36% |
| Oct 31, 2025 | -67.29% |
| Jul 31, 2025 | -131.57% |
| Apr 30, 2025 | -24.27% |
| Jan 31, 2025 | -911.25% |
| Oct 31, 2024 | -151.33% |
| Jul 31, 2024 | -197.09% |
| Apr 30, 2024 | 287.01% |
| Jan 31, 2024 | -53.69% |
| Oct 31, 2023 | -93,854.41% |
| Jul 31, 2023 | -120,274.35% |
| Apr 30, 2023 | -108.09% |
| Jan 31, 2023 | -88.57% |
| Oct 31, 2022 | -150.93% |
| Jul 31, 2022 | -214.20% |
| Apr 30, 2022 | -81.83% |
| Jan 31, 2022 | -69.16% |
| Oct 31, 2021 | -94.09% |
| Jul 31, 2021 | -75.56% |